A Leader in Rapid Point-of-Care Diagnostics.
Alere™ i is now ID NOW™
ID NOW™ is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases.Discover more
Introducing The New Afinion™ 2 Analyzer
Our next-gen analyzer for diabetes management arms you with critical information to make decisions faster.Discover more
Afinion™ HbA1c Dx
The first-ever POC HbA1c test cleared for diagnosis
Finally, an HbA1c test that can be used as an aid to diagnose and monitor patients with diabetes or pre-diabetes at the point of care.Discover Diagnosis in Minutes
Monitor and Diagnose Patients with Diabetes and Pre-Diabetes with the AfinionTM 2 System
See how you can improve patient outcomes with the AfinionTM 2 system - providing you with highly accurate results in minutes at the point of care.
Get your complimentary quick guide from Guideline Central on the new C. difficile infection guidelines published by IDSA and SHEA.
Antimicrobial resistance is a huge global health issue and contributes significantly to patient mortality and rising healthcare costs across the world. Visit TestTargetTreat.com now.
Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Abbott brings you a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world.